{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:41:59Z","timestamp":1789141319823,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"am","delay-in-days":277,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.radonc.2019.11.016","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T18:53:36Z","timestamp":1575399216000},"page":"141-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Long-term follow-up experience in anal canal cancer treated with Intensity-Modulated Radiation Therapy: Clinical outcomes, patterns of relapse and predictors of failure"],"prefix":"10.1016","volume":"144","author":[{"given":"Ma\u00eflys","family":"de Meric de Bellefon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Lemanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Castan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Samalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Mazard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Lenglet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Demontoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Riou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Llacer-Moscardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Fenoglietto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Aill\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Thezenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Debrigode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Vieillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Gourgou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Azria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2019.11.016_b0005","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","article-title":"Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)","volume":"102","author":"Northover","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2019.11.016_b0010","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"Bartelink","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2019.11.016_b0015","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98\u201311 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Gunderson","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2019.11.016_b0020","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","article-title":"Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study","volume":"14","author":"Flam","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2019.11.016_b0025","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 \u00d7 2 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2019.11.016_b0030","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000071200","article-title":"Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy","volume":"65","author":"Graf","year":"2003","journal-title":"Oncology"},{"key":"10.1016\/j.radonc.2019.11.016_b0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1748-717X-2-41","article-title":"Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans","volume":"2","author":"Menkarios","year":"2007","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2019.11.016_b0040","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.radonc.2009.07.006","article-title":"A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy","volume":"93","author":"Devisetty","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.11.016_b0045","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1002\/cncr.25901","article-title":"Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal","volume":"117","author":"Bazan","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2019.11.016_b0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijrobp.2003.10.032","article-title":"Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing","volume":"59","author":"Eisbruch","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.11.016_b0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","article-title":"RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal","volume":"86","author":"Kachnic","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.11.016_b0060","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","article-title":"Elective clinical target volumes for conformal therapy in anorectal cancer: an RTOG consensus panel contouring atlas","volume":"74","author":"Myerson","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.11.016_b0065","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ijrobp.2009.09.029","article-title":"Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning","volume":"78","author":"Wright","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.11.016_b0070","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1748-717X-7-45","article-title":"IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center","volume":"7","author":"Vieillot","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2019.11.016_b0075","unstructured":"Welton ML, Steele SR, Goodman KA, et al. Anus. In: AJCC cancer staging manual, 8th ed, Amin MB (Ed), AJCC, Chicago 2017. p. 275. n.d."},{"key":"10.1016\/j.radonc.2019.11.016_b0080","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.ijrobp.2005.05.062","article-title":"Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy","volume":"63","author":"Taylor","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.11.016_b0085","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1748-717X-5-92","article-title":"Plan comparison of volumetric-modulated arc therapy (RapidArc) and conventional intensity-modulated radiation therapy (IMRT) in anal canal cancer","volume":"5","author":"Vieillot","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2019.11.016_b0090","unstructured":"National Cancer Institute [Internet]. Common Terminology Criteria for Adverse Events (CTCAE) version 4.0. Available from: https:\/\/www.EortcBe\/Services\/Doc\/Ctc\/CTCAE_403_2010-06-14_QuickReference_5x7Pdf n.d."},{"key":"10.1016\/j.radonc.2019.11.016_b0095","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.ijrobp.2017.06.159","article-title":"Oncology\/RTOG 0529: long-term outcomes of dose-painted intensity modulated radiation therapy, 5-fluorouracil, and mitomycin-C in anal canal Cancer","volume":"99","author":"Kachnic","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.11.016_b0100","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2011.35.4837","article-title":"Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial","volume":"30","author":"Peiffert","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2019.11.016_b0105","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0360-3016(01)01510-3","article-title":"The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy","volume":"50","author":"Weber","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.11.016_b0110","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1200\/JCO.2010.29.1351","article-title":"Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87\u201304 and 98\u201311","volume":"28","author":"Ben-Josef","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2019.11.016_b0115","first-page":"10","article-title":"Prognostic factors for squamous cell cancer of the anal canal","volume":"2","author":"Das","year":"2008","journal-title":"Gastrointest Cancer Res"},{"key":"10.1016\/j.radonc.2019.11.016_b0120","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1245\/s10434-015-4391-9","article-title":"The role of FDG-PET in the initial staging and response assessment of anal cancer: a systematic review and meta-analysis","volume":"22","author":"Jones","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.radonc.2019.11.016_b0125","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1080\/0284186X.2017.1325003","article-title":"PET-CT guided SIB-IMRT combined with concurrent 5-FU\/MMC for the treatment of anal cancer","volume":"56","author":"Zimmermann","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2019.11.016_b0130","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ijrobp.2011.12.058","article-title":"Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer","volume":"83","author":"Ng","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.11.016_b0135","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ijrobp.2006.12.052","article-title":"Predictors and patterns of recurrence after definitive chemoradiation for anal cancer","volume":"68","author":"Das","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.11.016_b0140","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2012.30.15_suppl.4029","article-title":"The pattern and timing of disease recurrence in squamous cancer of the anus: mature results from the NCRI ACT II trial","volume":"30","author":"Sebag-Montefiore","year":"2012","journal-title":"JCO"},{"key":"10.1016\/j.radonc.2019.11.016_b0145","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3109\/0284186X.2015.1124141","article-title":"Clinical outcome in patients treated with simultaneous integrated boost \u2013 intensity modulated radiation therapy (SIB-IMRT) with and without concurrent chemotherapy for squamous cell carcinoma of the anal canal","volume":"55","author":"Tomasoa","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2019.11.016_b0150","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/ajco.12768","article-title":"Image-guided IMRT with simultaneous integrated boost as per RTOG 0529 for the treatment of anal cancer","volume":"14","author":"Arcadipane","year":"2018","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.radonc.2019.11.016_b0155","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/COC.0000000000000322","article-title":"Vulvar recurrences after intensity-modulated radiation therapy for squamous cell carcinoma of the anus","volume":"41","author":"Bagshaw","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.radonc.2019.11.016_b0160","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/0360-3016(89)90520-8","article-title":"Radiotherapy for anal cancer: experience from 1979\u20131987","volume":"17","author":"Hughes","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.11.016_b0165","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0167-8140(93)90076-K","article-title":"Chemoradiation therapy for anal cancer: radiation plus continuous infusion of 5-fluorouracil with or without cisplatin","volume":"27","author":"Rich","year":"1993","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.11.016_b0170","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/roi.2970020307","article-title":"Chemoradiotherapy for anal carcinoma: What is the optimal radiation dose?","volume":"2","author":"Fung","year":"1994","journal-title":"Radiat Oncol Investigat"},{"key":"10.1016\/j.radonc.2019.11.016_b0175","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0360-3016(97)00329-5","article-title":"Time-dose considerations in the treatment of anal cancer","volume":"39","author":"Constantinou","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.11.016_b0180","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.radonc.2008.05.001","article-title":"Radiation dose associated with local control in advanced anal cancer: Retrospective analysis of 129 patients","volume":"87","author":"Widder","year":"2008","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.radonc.2019.11.016_b0185","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.radonc.2018.08.008","article-title":"Prognostic factors of colostomy free survival in patients presenting with locally advanced anal canal carcinoma: a pooled analysis of two prospective trials (KANAL 2 and ACCORD 03)","volume":"129","author":"Faivre","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.11.016_b0190","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijrobp.2007.12.027","article-title":"Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92\u201308","volume":"72","author":"Konski","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.11.016_b0195","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3109\/0284186X.2013.770599","article-title":"Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors","volume":"52","author":"Bentzen","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2019.11.016_b0200","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.11.016_b0205","first-page":"39","article-title":"Intensity-modulated radiation therapy vs. 3D conformal radiation therapy for squamous cell carcinoma of the anal canal","volume":"6","author":"Chuong","year":"2013","journal-title":"Gastrointest Cancer Res"},{"key":"10.1016\/j.radonc.2019.11.016_b0210","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1080\/0284186X.2018.1503713","article-title":"Late gastrointestinal toxicity after radiotherapy for anal cancer: a systematic literature review","volume":"57","author":"Pan","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2019.11.016_b0215","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/IJWH.S106796","article-title":"Radiation-induced vaginal stenosis: current perspectives","volume":"9","author":"Morris","year":"2017","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.radonc.2019.11.016_b0220","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/COC.0b013e31827e52a3","article-title":"Intensity-modulated radiation therapy with concurrent chemotherapy for anal cancer: outcomes and toxicity","volume":"37","author":"Mitchell","year":"2014","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.radonc.2019.11.016_b0225","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.radonc.2012.05.011","article-title":"Reproducibility and genital sparing with a vaginal dilator used for female anal cancer patients","volume":"104","author":"Briere","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.11.016_b0230","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2329::AID-CNCR6>3.0.CO;2-G","article-title":"The impact of treatment factors on local control in T2\u2013T3 anal carcinomas treated by radiotherapy with or without chemotherapy","volume":"79","author":"Allal","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2019.11.016_b0235","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.prro.2014.09.003","article-title":"Clinical and treatment factors associated with vaginal stenosis after definitive chemoradiation for anal canal cancer","volume":"5","author":"Mirabeau-Beale","year":"2015","journal-title":"Pract Radiat Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814019334863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814019334863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:09:25Z","timestamp":1759122565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814019334863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":47,"alternative-id":["S0167814019334863"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2019.11.016","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term follow-up experience in anal canal cancer treated with Intensity-Modulated Radiation Therapy: Clinical outcomes, patterns of relapse and predictors of failure","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2019.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}